Neoplasm
Not recruitingStudy of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations
France- Participants:18–64 years · 65+ years
- Substances:Olaparib
- Sponsor:Merck Sharp & Dohme LLC
Rare diseases
Investigational molecules
Locations
Back to France807 clinical trials in Dijon, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for head and neck cancer, gastric cancer, and multiple types of lung cancer. Research encompasses novel therapeutic approaches and targeted treatments.
Several studies are evaluating new combination therapies and immunotherapy approaches for better treatment outcomes.
Research focusing on immune system responses and vaccine development, with particular emphasis on COVID-19 prevention and treatment strategies. Studies include innovative approaches to boosting immunity.
Trials are investigating both intranasal and traditional vaccination methods for optimal immune response.
Studies focusing on heart disease management and prevention, including innovative treatments for acute myocardial infarction and heart failure prevention strategies.
Research includes novel pain management approaches and preventive treatments for cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.